Sorry, you need to enable JavaScript to visit this website.
Skip to main content
 

Search

Washington University Research Alliance

Research Alliance Marks Innovative Collaboration in Type 1 Diabetes

Partnerships

Partnerships

Wendy Olsen, lincs
Wendy Olsen, lincs

Cardiovascular & Metabolism

Cardiovascular & Metabolism

Micro Pancreas
Micro Pancreas

Disease Interception Accelerator

Disease Interception Accelerator

World Without Disease Accelerator

World Without Disease Accelerator

istock
 

The Disease Interception Accelerator and Janssen Pharmaceuticals, Inc. entered into a research agreement with Washington University and award-winning immunologist Emil Unanue, M.D., Paul & Ellen Lacy Professor of Pathology & Immunology at Washington University, to identify the root cause of type 1 diabetes and enable the development of interventions that halt progression to disease.